Cost of illness of Heart Valve Diseases (HVDs): A real-world analysis in Italy
DOI:
https://doi.org/10.33393/grhta.2025.3243Keywords:
Direct costs, Economic burden, Heart Valve Diseases (HVD), Indirect costs, Italy, Real-world evidenceAbstract
Introduction: Heart valve diseases constitute a significant public health challenge with substantial clinical and economic implications. The ageing population, coupled with advancements in surgical techniques, has led to increased hospitalizations for cardiac valve interventions over the past decade. Despite progress, the economic burden of heart valve diseases remains underexplored, particularly in the context of the Italian healthcare system. This study aims to comprehensively assess the economic burden of heart valve diseases in Italy through a real-world analysis.
Methods: Using data from the national Italian Hospital Discharge Records (SDO), we identified the number of adult patients undergoing interventions on the aortic, mitral, and tricuspid valves, along with the associated costs borne by the National Health System. Additionally, we estimated indirect costs by analyzing social security benefit applications related to valve diseases from 2016 to 2019.
Results: A notable rise in hospitalizations for cardiac valve interventions, particularly for the aortic (+53.3%) and mitral valves (+29.5%) was revealed through the study period. In-hospital mortality rates declined, reflecting advancements in perioperative care. The economic burden of heart valve diseases in Italy was substantial, with hospitalization costs reaching €808 million in 2018. Social security benefit applications also increased, adding an annual cost of €29 million.
Conclusions: Heart valve diseases represent a growing clinical and socio-economic challenge in Italy. This study underscores the imperative for a multidisciplinary approach to effectively manage these conditions. Emphasizing prevention, early diagnosis, and timely interventions is crucial to mitigate the economic impact and enhance the quality of life for patients.
Downloads
References
Istituto Superiore di Sanità. Valvulopatie. Online https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/v/valvulopatie#:~:text=Possono%20essere%20gi%C3%A0%20presenti%20alla,endocardite%20rottura%20di%20corde%20tendinee (Accessed August 2024)
Ministero della Salute. Malattie Delle Valvole Cardiache. Online https://www.salute.gov.it/portale/alleanzaCardioCerebrovascolari/dettaglioSchedeAlleanzaCardioCerebrovascolari.jsp?lingua=italiano&id=36&area=Alleanza%20italiana%20per%20le%20malattie%20cardio-cerebrovascolari&menu=malattie (Accessed August 2024)
Azraai M, Gao L, Ajani AE. Cost-Effectiveness of Transcatheter Aortic Valve Intervention (TAVI) Compared to Surgical Aortic Valve Replacement (SAVR) in Low- to Intermediate-Surgical-Risk Patients. Cardiovasc Revasc Med. 2020 Sep;21(9):1164-1168. DOI: https://doi.org/10.1016/j.carrev.2020.01.009 PMID: 31980399. DOI: https://doi.org/10.1016/j.carrev.2020.01.009
Doyle MP, Woldendorp K, Ng M, Vallely MP, Wilson MK, Yan TD, Bannon PG. Minimally-invasive versus transcatheter aortic valve implantation: systematic review with meta-analysis of propensity-matched studies. J Thorac Dis. 2021 Mar;13(3):1671-1683. DOI: https://doi.org/10.21037/jtd-20-2233 PMID: 33841958 DOI: https://doi.org/10.21037/jtd-20-2233
Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014 Sep;30(9):962-970. DOI: https://doi.org/10.1016/j.cjca.2014.03.022 PMID: 24986049. DOI: https://doi.org/10.1016/j.cjca.2014.03.022
Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532. DOI: https://doi.org/10.1016/j.jacc.2019.10.009 PMID: 31727292 DOI: https://doi.org/10.1016/j.jacc.2019.10.009
Roth GA, Mensah GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. J Am Coll Cardiol. 2020 Dec 22;76(25):2980-2981. DOI: https://doi.org/10.1016/j.jacc.2020.11.021 PMID: 33309174 DOI: https://doi.org/10.1016/j.jacc.2020.11.021
d’Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515-3522. DOI: https://doi.org/10.1093/eurheartj/ehw229 PMID:27354049 DOI: https://doi.org/10.1093/eurheartj/ehw229
Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897-902. DOI: DOI: https://doi.org/10.1016/S0002-9149(98)01064-9 PMID:10190406 DOI: https://doi.org/10.1016/S0002-9149(98)01064-9
Prihadi EA, van der Bijl P, Gursoy E, et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur Heart J. 2018;39(39):3574-3581. DOI: https://doi.org/10.1093/eurheartj/ehy352 PMID:30010848 DOI: https://doi.org/10.1093/eurheartj/ehy352
Corriere della Sera. Corriere Salute. Screening per il cuore, la diagnosi precoce potrebbe salvare la vita a 150mila persone l’anno. Online https://www.corriere.it/salute/cardiologia/23_luglio_05/screening-il-cuore-diagnosi-precoce-potrebbe-salvare-vita-150mila-persone-l-anno-337694d6-1a81-11ee-803d-db3b1d875840.shtml (Accessed August 2024)
Moore M, Chen J, Mallow PJ, Rizzo JA. The direct health-care burden of valvular heart disease: evidence from US national survey data. Clinicoecon Outcomes Res. 2016;8:613-627. DOI: https://doi.org/10.2147/CEOR.S112691 PMID:27799803 DOI: https://doi.org/10.2147/CEOR.S112691
Trochu JN, Le Tourneau T, Obadia JF, Caranhac G, Beresniak A. Economic burden of functional and organic mitral valve regurgitation. Arch Cardiovasc Dis. 2015;108(2):88-96. DOI: https://doi.org/10.1016/j.acvd.2014.09.008 PMID:25662004 DOI: https://doi.org/10.1016/j.acvd.2014.09.008
Galper BZ, Chinnakondepalli KM, Wang K, et al; PARTNER Investigators. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: results from the PARTNER 3 Trial. Circulation. 2023;147(21):1594-1605. DOI: https://doi.org/10.1161/CIRCULATIONAHA.122.062481 PMID:37154049 DOI: https://doi.org/10.1161/CIRCULATIONAHA.122.062481
Cork DP, McCullough PA, Mehta HS, et al. The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database. J Med Econ. 2020;23(5):521-528. DOI: https://doi.org/10.1080/13696998.2020.1718681 PMID:31952454 DOI: https://doi.org/10.1080/13696998.2020.1718681
Berti E, Fortuna D, Bartoli S, et al. [Transcatheter aortic valve implantation versus aortic valve replacement: cost analysis from the regional health service and hospital perspectives]. G Ital Cardiol (Rome). 2016;17(12)(suppl 1):22S-30. PMID:28151532
Santarpino G, Lorusso R, Moscarelli M, et al. Sutureless versus transcatheter aortic valve replacement: A multicenter analysis of “real-world” data. J Cardiol. 2022;79(1):121-126. DOI: https://doi.org/10.1016/j.jjcc.2021.08.022 PMID:34518075 DOI: https://doi.org/10.1016/j.jjcc.2021.08.022
Kotseva K, Gerlier L, Sidelnikov E, et al. Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. Eur J Prev Cardiol. 2019;26(11):1150-1157. DOI: https://doi.org/10.1177/2047487319834770 PMID:30955367 DOI: https://doi.org/10.1177/2047487319834770
Cebr. The Economic Cost of Cardiovascular Disease from 2014-2020 in Six European Economies. https://munideporte.com/imagenes/documentacion/ficheros/02E9FB14.pdf (Accessed August 2024)
Russo S, Mariani TT, Migliorini R, Marcellusi A, Mennini FS. The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation. Reumatismo. 2015;67(2):45-56. DOI: https://doi.org/10.4081/reumatismo.2015.811 PMID:26492962 DOI: https://doi.org/10.4081/reumatismo.2015.811
Mauri V, Abdel-Wahab M, Bleiziffer S, et al. Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013-2020. Clin Res Cardiol. 2022;111(8):881-888. DOI: https://doi.org/10.1007/s00392-021-01963-3 PMID:34751789 DOI: https://doi.org/10.1007/s00392-021-01963-3
Stortecky S, Franzone A, Heg D, et al. Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis. Eur Heart J Qual Care Clin Outcomes. 2019;5(3):242-251. DOI: https://doi.org/10.1093/ehjqcco/qcy048 PMID:30304513 DOI: https://doi.org/10.1093/ehjqcco/qcy048
Auffret V, Lefevre T, Van Belle E, et al; FRANCE TAVI Investigators. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol. 2017;70(1):42-55. DOI: https://doi.org/10.1016/j.jacc.2017.04.053 PMID:28662806 DOI: https://doi.org/10.1016/j.jacc.2017.04.053
Paparella D, Fattouch K, Moscarelli M, et al. Current trends in mitral valve surgery: A multicenter national comparison between full-sternotomy and minimally-invasive approach. Int J Cardiol. 2020;306:147-151. DOI: https://doi.org/10.1016/j.ijcard.2019.11.137 PMID:31810816 DOI: https://doi.org/10.1016/j.ijcard.2019.11.137
Elbadawi A, Elgendy IY, Mohamed AH, et al. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention. Cardiovasc Revasc Med. 2020 Dec;21(12):1560-1566. DOI: 10.1016/j.carrev.2020.05.021 PMID: 32620401. DOI: https://doi.org/10.1016/j.carrev.2020.05.021
Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017;70(24):2953-2960. DOI: https://doi.org/10.1016/j.jacc.2017.10.039 PMID:29241483 DOI: https://doi.org/10.1016/j.jacc.2017.10.039
Torres C, Lozier MR, Davidson CJ, et al. In-Hospital Outcomes of Transcatheter Tricuspid Valve Repair: An Analysis From the National Inpatient Sample. J Soc Cardiovasc Angiogr Interv. 2022;1(5):100414. DOI: https://doi.org/10.1016/j.jscai.2022.100414 PMID:39131469 DOI: https://doi.org/10.1016/j.jscai.2022.100414
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med Sci (Basel). 2022 Jun 15;10(2):32. DOI: https://doi.org/10.3390/medsci10020032 PMID: 3573635 DOI: https://doi.org/10.3390/medsci10020032
Ambrosy AP, Go AS, Leong TK, et al. Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort. Int J Cardiol. 2023;384:107-111. DOI: https://doi.org/10.1016/j.ijcard.2023.04.047 PMID:37119944 DOI: https://doi.org/10.1016/j.ijcard.2023.04.047
Masiero G, Musumeci G. Transcatheter aortic valve implantation in Italy: an uneven growth. Eur Heart J Suppl. 2020;22(suppl E):E96-E100. DOI: https://doi.org/10.1093/eurheartj/suaa070 PMID:32523449 DOI: https://doi.org/10.1093/eurheartj/suaa070
Tarantini G, et al. [Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]. G Ital Cardiol (Rome). 2018;19: 519-529
https://doi.org/10.1714/2951.29672 PMID: 30087514
Dimagli A, Sinha S, Caputo M, Angelini GD, Benedetto U. Trend in morbidity and mortality in surgical aortic valve replacement: a retrospective, observational, single-centre study. Interact Cardiovasc Thorac Surg. 2020;31(6):796-802. DOI: https://doi.org/10.1093/icvts/ivaa189 PMID:33150396 DOI: https://doi.org/10.1093/icvts/ivaa189
Mattke S, Schneider S, Orr P, Lakdawalla D, Goldman D. Temporal Trends in Mortality after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Regression Analysis. Struct Heart. 2020;4(1):16-23. DOI: https://doi.org/10.1080/24748706.2019.1689321 DOI: https://doi.org/10.1080/24748706.2019.1689321
Kolte D, Kennedy KF, Passeri JJ, Inglessis I, Elmariah S. Temporal Trends in Prevalence of Tricuspid Valve Disease in Hospitalized Patients in the United States. Am J Cardiol. 2020;125(12):1879-1883. DOI: https://doi.org/10.1016/j.amjcard.2020.03.033 PMID:32303339 DOI: https://doi.org/10.1016/j.amjcard.2020.03.033
Shariff M, Kumar A, Hirji SA, Majmundar M, Adalja D, Doshi R. Ten Years Mortality Trends of Tricuspid Regurgitation in the United States, 2008 to 2018. Am J Cardiol. 2021 Feb 1;140:156-157. DOI: https://doi.org/10.1016/j.amjcard.2020.11.024 PMID: 33259799 DOI: https://doi.org/10.1016/j.amjcard.2020.11.024
Tan MC, Yeo YH, San BJ, et al. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020. J Am Heart Assoc. 2024;13(8):e030895. DOI: https://doi.org/10.1161/JAHA.123.030895 PMID:38587138 DOI: https://doi.org/10.1161/JAHA.123.030895
Areces S, Hernández-Vaquero D, Avanzas P, García-Aranda FJ, Silva J, Morís C. Cost comparison between transcatheter aortic valve implantation and surgical valve replacement using individual data in a Spanish public hospital. Cir Cardiovasc. 2021;28(6):317-324.DOI: https://doi.org/10.1016/j.circv.2021.07.006 DOI: https://doi.org/10.1016/j.circv.2021.07.006
Perin G, Shaw M, Toolan C, Palmer K, Al-Rawi O, Modi P. Cost Analysis of Minimally Invasive Mitral Valve Surgery in the UK National Health Service. Ann Thorac Surg. 2021;112(1):124-131. DOI: https://doi.org/10.1016/j.athoracsur.2020.08.020 PMID:33068544 DOI: https://doi.org/10.1016/j.athoracsur.2020.08.020
Alperi A, Almendárez M, Álvarez R, Moris C, Leon V, Silva I, Hernández-Vaquero D, Pascual I, Avanzas P. Transcatheter tricuspid valve interventions: Current status and future perspectives. Front Cardiovasc Med. 2022 Sep 14;9:994502. DOI: https://doi.org/10.3389/fcvm.2022.994502. PMID: 36187002 DOI: https://doi.org/10.3389/fcvm.2022.994502
Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation. J Am Heart Assoc. 2017;6(12):e007597. DOI: https://doi.org/10.1161/JAHA.117.007597 PMID:29273638 DOI: https://doi.org/10.1161/JAHA.117.007597
Masaebi F, Salehi M, Kazemi M, Vahabi N, Azizmohammad Looha M, Zayeri F. Trend analysis of disability adjusted life years due to cardiovascular diseases: results from the global burden of disease study 2019. BMC Public Health. 2021;21(1):1268. DOI: https://doi.org/10.1186/s12889-021-11348-w PMID:34187450 DOI: https://doi.org/10.1186/s12889-021-11348-w
Agenas. Programma Nazionale Esiti. Edizione 2023. Online https://pne.agenas.it/assets/documentation/report/agenas_pne_report_2023.pdf (Accessed August 2024)
Amico MA, Busi G, Vannini M, et al. PREVASC: prospective registry of epidemiology of valve disease in asymptomatic italian subjects [Internet]. 2024. Online https://academic.oup.com/eurjpc/article/31/Supplement_1/zwae175.447/7692452 (Accessed August 2024) DOI: https://doi.org/10.1093/eurjpc/zwae175.447
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2025-01-14
Published 2025-02-19
